Table 2.
Comparison between females and males with and without metabolic syndrome (MetS). For significance: & p < 0.05 for the difference vs. females; * p < 0.005 for the difference vs. females.
| Number of Subjects | No MetS | MetS | ||
|---|---|---|---|---|
| Females | Males | Females | Males | |
| 41 | 34 | 28 | 17 | |
| Age yr | 28.1 ± 8.7 | 26.5 ± 9.2 | 31.7 ± 7.4 | 31.8 ± 11.1 |
| BMI | 34.2 ± 8.7 | 32.2 ± 9.1 | 44.1 ± 10.2 | 39.8 ± 5.7 |
| TMI | 23.1 ± 6.5 | 20.2 ± 6.1 | 29.7 ± 7.5 | 25.2 ± 3.8 & |
| BMFI | 19.2 ± 9.6 | 17.2 ± 9.9 | 30.9 ± 11.6 | 25.3 ± 7.2 |
| FMI | 17.3 ± 6.4 | 14.6 ± 6.4 | 23.6 ± 6.7 | 19.6 ± 4.1 & |
| WtHR | 0.7 ± 0.1 | 0.7 ± 0.1 | 0.8 ± 0.1 | 0.8 ± 0.1 |
| FFMI | 15.5 ± 2.3 | 16.4 ± 3.0 | 19.0 ± 3.8 | 18.6 ± 2.3 |
| WC (cm) | 101.3 ± 17.2 | 107.0 ± 15.9 | 124 ± 15.8 | 121.9 ± 14.1 |
| SBP (mm/Hg) | 116.0 ± 8.0 | 117.1 ± 7.3 | 125.4 ± 9.2 | 129.1 ± 7.8 |
| DBP (mm/Hg) | 74.4 ± 7.1 | 76.0 ± 5.5 | 78.6 ± 4.5 | 77.9 ± 5.3 |
| HDL-C (mg/dl) | 60.2 ± 14.3 | 50.9 ± 12.6 * | 47.1 ± 13.1 | 41.9 ± 14.4 |
| TG (mg/dl) | 81.0 ± 34.2 | 94.3 ± 40.8 | 129.3 ± 87.3 | 117.2 ± 42.2 |
| glycemia (mg/dl) | 84.6 ± 11.1 | 85.1 ± 8.4 | 129.3 ± 72.4 | 93.2 ± 15.4 & |
| HbA1c | 5.4 ± 0.4 | 5.4 ± 0.5 | 4.4 ± 0.5 | 5.9 ± 0.6 & |
| insulin | 8.7 ± 5.6 | 9.3 ± 4.2 | 11.6 ± 5.3 | 17.4 ± 10.4 & |